Another study found that a specific agonist, polyphyllin VI (PPVI), activates the ROS/NF-κB/NLRP3/GSDMD signaling pathway to inhibit non-small cell lung cancer (NSCLC). The gene discussed is NLRP3; the disease is non-small cell lung carcinoma.